| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |